Where did our name come from?

We’re called Q’Apel for the Qu’Appelle River, a waterway that winds through Saskatchewan, Canada. Why? Because this pristine river charts a winding path, full of twists, turns, and straightaways alike. That’s what we do, too. Our cutting-edge products—neurological catheters, specifically—are designed to navigate the twists and turns of the brain’s neurovasculature, empowering therapeutic thrombectomy and cerebral aneurysm devices to deliver life-changing outcomes.

Who We Are
View All Resources

Q’Apel Medical Welcomes Jodie Fam, Vice President and General Manager, International

May 17, 2021

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device technology for vascular interventions, is pleased to announce and welcome Jodie Fam as Vice President and General Manager, International. Jodie will be responsible for the leadership and development of International Sales for Q’Apel. Jodie brings more than 20 years of medical device industry experience. She has a solid track record in building global and geographical operations, developing and implementing strategies for market development, sales leadership and driving commercial value for both major medtech companies and several venture-backed start-ups.

“We are thrilled to have Jodie on board. She brings a strong international commercial perspective and leadership to the Q’Apel team. Her multifaceted background, industry experience, and successful track record of building global operations, is the perfect match for our company, and Jodie will be instrumental in helping us bring our differentiated technologies to the international markets.”

King Nelson, CEO of Q’Apel Medical

“I am delighted to join Q’Apel Medical to architect the International expansion and growth for the company. Joining a team with such passion and novel technology is reflected in my own desire to make for better procedures for physicians and outcomes for patients.”

Jodie Fam.

Q’Apel Medical plans to acquire CE Certification and expand into Europe later this year. Q’Apel Medical products are currently being utilized in over 160 hospital systems nationwide.

About Q’Apel Medical:

Q’Apel Medical designs highly innovative technologies for vascular interventions and unmet clinical needs. Q’Apel’s core portfolio comprises two products, the Walrus Balloon Catheter System and the Wahoo Hybrid Access System. Before Walrus came along, balloon-based variable stiffness catheters brought all manner of technological constraints. Not anymore. By blending flow control, trackability, support, and access into one revolutionary solution, Walrus offers truly unmatched functionality. The Wahoo Hybrid Access System is a dual-mode catheter complete with two distinct operational modes, allowing physicians to easily switch modes at any point during a clinical case and reducing the need for multiple catheters in challenging procedures. In the precious seconds that surround a stroke emergency, clinicians need technology that serves their needs in the moment, and an innovation pipeline that anticipates what they’ll need next. This is Q’Apel Medical’s utmost aspiration and continual target.

Media Contact: Q’Apel Medical

Related readings.

Our utmost commitment: creating what works based specifically and urgently on what’s needed. Explore additional resources, publications, and webinars to learn more.

October 12, 2021

Q’Apel Medical, Inc. Awarded U.S. Patent for its Highly Innovative SelectFlex™ Technology

August 23, 2021

Q’Apel Medical Launches Armadillo – A New Radial Artery Access Platform to Meet the Needs of Physicians and Patients

August 9, 2021

Q’Apel Medical Welcomes Thomas Berryman, Chief Financial Officer

July 27, 2021

Q’Apel Medical Announces Move to New Headquarters Facility in Fremont, CA